Publication

Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    Nina Alexander, Duke UniversityBarbara D. Lortholary, Hôpital Necker-Enfants maladesOliver Dromer, Hôpital Necker-Enfants maladesFrancoise Gupta, Postgraduate Institute of Medical Education and ResearchKrishan L. John, Christian Medical College HospitalGeorge T. del Busto, Henry Ford HospitalRamon Klintmalm, Baylor UniversityGoran B. Somani, Emory UniversityJyoti Lyon III, Emory UniversityNina Singh, University of PittsburghKenneth Pursell, University of ChicagoValentina Stosor, Northwestern UniversityPatricia Munoz, Hospital General Universitario Gregorio MaraňónAjit P. Limaye, University of WashingtonAndre C. Kalil, University of NebraskaTimothy L. Pruett, University of VirginiaJulia Garcia-Diaz, Ochsner ClinicAtul Humar, Toronto General HospitalSally Houston, University of South Florida
Language
  • English
Date
  • 2008-01-15
Publisher
  • Oxford University Press (OUP): Policy B - Oxford Open Option C
Publication Version
Copyright Statement
  • © 2007 by the Infectious Diseases Society of America. All rights reserved.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1058-4838
Volume
  • 46
Issue
  • 2
Start Page
  • E12
End Page
  • E18
Grant/Funding Information
  • Supported by NIH/NIAID award R01 AI 054719-01 to NS.
Abstract
  • Background: The role of serum cryptococcal antigen in the diagnosis and determinants of antigen positivity in solid organ transplant (SOT) recipients with pulmonary cryptococcosis has not been fully defined. Methods: We conducted a prospective, multicenter study of SOT recipients with pulmonary cryptococcosis during 1999-2006. Results: Forty (83%) of 48 patients with pulmonary cryptococcosis tested positive for cryptococcal antigen. Patients with concomitant extrapulmonary disease were more likely to have a positive antigen test result (P = .018), and antigen titers were higher in patients with extrapulmonary disease (P = .003) or fungemia (P = .045). Patients with single nodules were less likely to have a positive antigen test result than were those with all other radiographic presentations (P = .053). Among patients with isolated pulmonary cryptococcosis, lung transplant recipients were less likely to have positive cryptococcal antigen test results than were recipients of other types of SOT (Pp.003). In all, 38% of the patients were asymptomatic or had pulmonary cryptococcosis detected as an incidental finding. Nodular densities or mass lesions were more likely to present as asymptomatic or incidentally detected pulmonary cryptococcosis than as pleural effusions and infiltrates (P = .008). Conclusions: A positive serum cryptococcal antigen test result in SOT recipients with pulmonary cryptococcosis appears to reflect extrapulmonary or more advanced radiographic disease.
Author Notes
  • Nina Singh, Infectious Diseases Section, VA Medical Center, University drive C, Pittsburgh, PA 15240.Phone: 412-688-6179,fax 412-688-6950, nis5@pitt.edu
Keywords
Research Categories
  • Biology, Microbiology
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items